Home › Funds › Redmile Group, LLC › DBVT

Redmile Group, LLC position in DBVT

DBV TECHNOLOGIES S A · Health Care

Redmile Group, LLC reported holding 410,440 shares of DBVT (DBV TECHNOLOGIES S A) in its Q2 2026 13F filing — a position valued at US$6.7M, representing 0.45% of its reported portfolio and ranking #31 among its reported holdings. Redmile Group, LLC has disclosed DBVT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)410.44K sh
Reported value held$6.73M
Portfolio Weight0.45%
First reportedQ4 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Redmile Group, LLC's DBVT position evolved

Redmile Group, LLC first disclosed a stake in DBVT in Q4 2025 at 549,840 shares (US$10.5M). Across 3 filings, Redmile Group, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 410,440 shares valued at US$6.7M — a reduction of -80,900 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 549.84K $10.54M New
Q1 2026 491.34K $10.26M Reduce
Q2 2026 410.44K $6.73M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DBVT and 13F data

DBVT (DBV TECHNOLOGIES S A) is a Health Care company. 57 other funds we track also report a position in DBVT — the largest reported positions include MPM BioImpact LLC (US$60.1M), Siren, L.L.C. (US$30.5M), Vivo Capital, LLC (US$30.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DBVT

All DBVT fund holders →

FAQ

How long has Redmile Group, LLC held DBVT?

Redmile Group, LLC has disclosed DBVT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Redmile Group, LLC's current position in DBVT?

As of Q2 2026, Redmile Group, LLC holds 410.44K shares of DBVT (DBV TECHNOLOGIES S A), valued at $6.73M, representing 0.45% of its reported portfolio and ranking #31.

Has Redmile Group, LLC been buying or selling DBVT?

In the latest 13F filing (Q2 2026), Redmile Group, LLC reduced its position in DBVT.

Which other funds hold DBVT?

Other major institutional holders of DBVT include MPM BioImpact LLC, Siren, L.L.C., Vivo Capital, LLC, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.